Group items tagged

Active specific immunotherapy with supportive measures in the treatment of advanced palliatively nephrectomised renal adenocarcinoma. A controlled clinical study. Tykkä H. Scand J Urol Nephrol Suppl. 1981;63:1-107. PMID: 6184775

Active specific immunotherapy of advanced renal-cell carcinoma. Tykkä H, Oravisto KJ, Lehtonen T, Sarna S, Tallberg T. Eur Urol. 1978;4(4):250-8. PMID: 668735

Active specific immunotherapy with supportive measures in the treatment of palliatively nephrectomized, renal adenocarcinoma patients. A thirteen-year follow-up study. Tallberg T, Tykkä H, Mahlberg K, Halttunen P, Lehtonen T, Kalima T, Sarna S. Eur Urol. 1985;11(4):233-43. PMID: 2412827

Postoperative active specific immunotherapy with supportive measures in patients suffering from recurrent metastasized melanoma: case reports of six patients.\nTallberg T, Kalima T, Halttunen P, Tykkä H, Mahlberg K, Matous B, Sundell B.\nJ Surg Oncol. 1986 Oct;33(2):115-9.\nPMID: 3762183

Macroscopical and histopathological changes in regressing primary and recurrent equine sarcoids during active specific bio-immunotherapy. Hallamaa RE, Saario E, Tallberg T. In Vivo. 2005 Jul-Aug;19(4):761-7. PMID: 15999546